Advanced search
1 file | 256.30 KB

PF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function

(2012) PLOS ONE. 7(2).
Author
Organization
Abstract
Background: Platelet-derived chemokines are implicated in several aspects of vascular biology. However, for the chemokine platelet factor 4 variant (PF-4var/CXCL4L1), released by platelets during thrombosis and with different properties as compared to PF-4/CXCL4, its role in heart disease is not yet studied. We evaluated the determinants and prognostic value of the platelet-derived chemokines PF-4var, PF-4 and RANTES/CCL5 in patients with stable coronary artery disease (CAD). Methodology/Principal Findings: From 205 consecutive patients with stable CAD and preserved left ventricular (LV) function, blood samples were taken at inclusion and were analyzed for PF-4var, RANTES, platelet factor-4 and N-terminal pro-B-type natriuretic peptide (NT-proBNP). Patients were followed (median follow-up 2.5 years) for the combined endpoint of cardiac death, non-fatal acute myocardial infarction, stroke or hospitalization for heart failure. Independent determinants of PF-4var levels (median 10 ng/ml; interquartile range 8-16 ng/ml) were age, gender and circulating platelet number. Patients who experienced cardiac events (n = 20) during follow-up showed lower levels of PF-4var (8.5 [5.3-10] ng/ml versus 12 [8-16] ng/ml, p = 0.033). ROC analysis for events showed an area under the curve (AUC) of 0.82 (95% CI 0.73-0.90, p<0.001) for higher NT-proBNP levels and an AUC of 0.32 (95% CI 0.19-0.45, p = 0.009) for lower PF-4var levels. Cox proportional hazard analysis showed that PF-4var has an independent prognostic value on top of NT-proBNP. Conclusions: We conclude that low PF-4var/CXCL4L1 levels are associated with a poor outcome in patients with stable CAD and preserved LV function. This prognostic value is independent of NT-proBNP levels, suggesting that both neurohormonal and platelet-related factors determine outcome in these patients.
Keywords
VARIANT, CELLS, IN-VIVO, HUMAN MONOCYTES, CXC-CHEMOKINE PLATELET-FACTOR-4, DIFFERENTIATION, CXCL4L1, ANGIOGENESIS, MACROPHAGES, INHIBITION

Downloads

  • DeSutter 2012 PO 7 2 e31343.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 256.30 KB

Citation

Please use this url to cite or link to this publication:

Chicago
De Sutter, Johan, Nico R van de Veire, Sofie Struyf, Jan Philippé, Marc De Buyzere, and Jo Van Damme. 2012. “PF-4var/CXCL4L1 Predicts Outcome in Stable Coronary Artery Disease Patients with Preserved Left Ventricular Function.” Plos One 7 (2).
APA
De Sutter, J., van de Veire, N. R., Struyf, S., Philippé, J., De Buyzere, M., & Van Damme, J. (2012). PF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function. PLOS ONE, 7(2).
Vancouver
1.
De Sutter J, van de Veire NR, Struyf S, Philippé J, De Buyzere M, Van Damme J. PF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function. PLOS ONE. 2012;7(2).
MLA
De Sutter, Johan, Nico R van de Veire, Sofie Struyf, et al. “PF-4var/CXCL4L1 Predicts Outcome in Stable Coronary Artery Disease Patients with Preserved Left Ventricular Function.” PLOS ONE 7.2 (2012): n. pag. Print.
@article{3033039,
  abstract     = {Background: Platelet-derived chemokines are implicated in several aspects of vascular biology. However, for the chemokine platelet factor 4 variant (PF-4var/CXCL4L1), released by platelets during thrombosis and with different properties as compared to PF-4/CXCL4, its role in heart disease is not yet studied. We evaluated the determinants and prognostic value of the platelet-derived chemokines PF-4var, PF-4 and RANTES/CCL5 in patients with stable coronary artery disease (CAD). 
Methodology/Principal Findings: From 205 consecutive patients with stable CAD and preserved left ventricular (LV) function, blood samples were taken at inclusion and were analyzed for PF-4var, RANTES, platelet factor-4 and N-terminal pro-B-type natriuretic peptide (NT-proBNP). Patients were followed (median follow-up 2.5 years) for the combined endpoint of cardiac death, non-fatal acute myocardial infarction, stroke or hospitalization for heart failure. Independent determinants of PF-4var levels (median 10 ng/ml; interquartile range 8-16 ng/ml) were age, gender and circulating platelet number. Patients who experienced cardiac events (n = 20) during follow-up showed lower levels of PF-4var (8.5 [5.3-10] ng/ml versus 12 [8-16] ng/ml, p = 0.033). ROC analysis for events showed an area under the curve (AUC) of 0.82 (95\% CI 0.73-0.90, p{\textlangle}0.001) for higher NT-proBNP levels and an AUC of 0.32 (95\% CI 0.19-0.45, p = 0.009) for lower PF-4var levels. Cox proportional hazard analysis showed that PF-4var has an independent prognostic value on top of NT-proBNP. 
Conclusions: We conclude that low PF-4var/CXCL4L1 levels are associated with a poor outcome in patients with stable CAD and preserved LV function. This prognostic value is independent of NT-proBNP levels, suggesting that both neurohormonal and platelet-related factors determine outcome in these patients.},
  articleno    = {e31343},
  author       = {De Sutter, Johan and van de Veire, Nico R and Struyf, Sofie and Philipp{\'e}, Jan and De Buyzere, Marc and Van Damme, Jo},
  issn         = {1932-6203},
  journal      = {PLOS ONE},
  keyword      = {VARIANT,CELLS,IN-VIVO,HUMAN MONOCYTES,CXC-CHEMOKINE PLATELET-FACTOR-4,DIFFERENTIATION,CXCL4L1,ANGIOGENESIS,MACROPHAGES,INHIBITION},
  language     = {eng},
  number       = {2},
  pages        = {8},
  title        = {PF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function},
  url          = {http://dx.doi.org/10.1371/journal.pone.0031343},
  volume       = {7},
  year         = {2012},
}

Altmetric
View in Altmetric
Web of Science
Times cited: